Annual report pursuant to Section 13 and 15(d)

CONDENSED FINANCIAL STATEMENTS (PARENT COMPANY ONLY) (Details)

v2.4.0.8
CONDENSED FINANCIAL STATEMENTS (PARENT COMPANY ONLY) (Details) (USD $)
0 Months Ended 3 Months Ended 12 Months Ended
Jun. 30, 2011
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
ASSETS                          
Cash and cash equivalents   $ 156,892,000       $ 226,358,000       $ 156,892,000 $ 226,358,000 $ 243,042,000  
Other assets   4,491,000       4,435,000       4,491,000 4,435,000    
Total assets   1,517,405,000       1,560,718,000       1,517,405,000 1,560,718,000    
LIABILITIES AND SHAREHOLDERS' EQUITY                          
Subordinated debt   0       1,650,000       0 1,650,000    
Long-term debt   41,238,000       41,238,000       41,238,000 41,238,000    
Total liabilities   1,384,883,000       1,430,211,000       1,384,883,000 1,430,211,000    
Total shareholders' equity   132,522,000       130,507,000       132,522,000 130,507,000 94,426,000 67,842,000
Total liabilities and shareholders' equity   1,517,405,000       1,560,718,000       1,517,405,000 1,560,718,000    
Expense                          
Interest expense                   7,337,000 9,814,000 14,480,000  
Income tax benefit                   4,270,000 (18,583,000) 0  
Net income   2,234,000 2,238,000 2,603,000 2,473,000 21,234,000 6,585,000 3,186,000 4,485,000 9,549,000 35,490,000 5,829,000  
Net income (loss) available to common shares                   (8,026,000) 35,490,000 5,829,000  
Comprehensive income                   6,634,000 36,072,000 6,196,000  
Cash flows from operating activities                          
Net income   2,234,000 2,238,000 2,603,000 2,473,000 21,234,000 6,585,000 3,186,000 4,485,000 9,549,000 35,490,000 5,829,000  
Adjustments to reconcile net income to net cash from operating activities:                          
Net cash from operating activities                   16,312,000 13,495,000 12,153,000  
Cash flows from investing activities                          
Net cash from investing activities                   (40,991,000) (44,048,000) 72,507,000  
Cash flows from financing activities                          
Proceeds from issuance of subordinated note and conversion to common stock                   0 0 1,000,000  
Proceeds from issuance of common stock 20,300,000                 0 0 19,319,000  
Repurchases of shares                   (45,000) 0 0  
Cash paid in preferred stock exchange                   (4,734,000) 0 0  
Net cash from financing activities                   (44,787,000) 13,869,000 (77,745,000)  
Net change in cash and cash equivalents                   (69,466,000) (16,684,000) 6,915,000  
Beginning cash and cash equivalents         226,358,000       243,042,000 226,358,000 243,042,000 236,127,000  
Ending cash and cash equivalents   156,892,000       226,358,000       156,892,000 226,358,000 243,042,000  
Supplemental noncash disclosures:                          
Conversion of subordinated note to 491,830 shares of common stock                   0 0 1,003,000  
Conversion of 300 shares of Preferred Series B to 50,000 shares of common stock                   300,000 0 0  
Exchange of 31,290 shares of Preferred Series A to 5,973,519 shares of common stock                   30,604,000 0 0  
Exchange of 2,300 shares of Preferred Series B to 457,159 shares of common stock                   2,260,000 0 0  
Parent Company [Member]
                         
ASSETS                          
Cash and cash equivalents   1,910,000       9,787,000       1,910,000 9,787,000 10,535,000  
Investments in Bank subsidiary   167,292,000       164,127,000       167,292,000 164,127,000    
Investment in other subsidiaries   1,504,000       1,654,000       1,504,000 1,654,000    
Other assets   3,272,000       2,532,000       3,272,000 2,532,000    
Total assets   173,978,000       178,100,000       173,978,000 178,100,000    
LIABILITIES AND SHAREHOLDERS' EQUITY                          
Subordinated debt   0       1,650,000       0 1,650,000    
Long-term debt   41,238,000       41,238,000       41,238,000 41,238,000    
Other liabilities   218,000       4,705,000       218,000 4,705,000    
Total liabilities   41,456,000       47,593,000       41,456,000 47,593,000    
Total shareholders' equity   132,522,000       130,507,000       132,522,000 130,507,000    
Total liabilities and shareholders' equity   173,978,000       178,100,000       173,978,000 178,100,000    
Income                          
Dividends from subsidiaries                   5,179,000 0 0  
Other                   0 0 0  
Total income                   5,179,000 0 0  
Expense                          
Interest expense                   1,563,000 1,719,000 1,598,000  
Other expense                   575,000 555,000 588,000  
Total expense                   2,138,000 2,274,000 2,186,000  
Income (loss) before income tax and equity in undistributed earnings of subsidiaries                   3,041,000 (2,274,000) (2,186,000)  
Equity in undistributed earnings of subsidiaries                   5,770,000 35,338,000 8,015,000  
Income before income tax                   8,811,000 33,064,000 5,829,000  
Income tax benefit                   (738,000) (2,426,000) 0  
Net income                   9,549,000 35,490,000 5,829,000  
Net income (loss) available to common shares                   (8,026,000) 35,490,000 5,829,000  
Comprehensive income                   (10,941,000) 36,072,000 6,196,000  
Cash flows from operating activities                          
Net income                   9,549,000 35,490,000 5,829,000  
Adjustments to reconcile net income to net cash from operating activities:                          
Equity in undistributed earnings of subsidiaries                   (5,770,000) (35,338,000) (8,015,000)  
(Increase) decrease in other assets                   (740,000) (2,424,000) 428,000  
Increase (decrease) in other liabilities                   (4,487,000) 1,524,000 1,395,000  
Net cash from operating activities                   (1,448,000) (748,000) (363,000)  
Cash flows from investing activities                          
Investment in subsidiaries                   0 0 (10,000,000)  
Net cash from investing activities                   0 0 (10,000,000)  
Cash flows from financing activities                          
Proceeds from issuance of subordinated note and conversion to common stock                   0 0 1,000,000  
Proceeds from issuance of common stock                   0 0 19,319,000  
Redemption of subordinated debt                   (1,650,000) 0 0  
Repurchases of shares                   (45,000) 0 0  
Cash paid in preferred stock exchange                   (4,734,000) 0 0  
Net cash from financing activities                   (6,429,000) 0 20,319,000  
Net change in cash and cash equivalents                   (7,877,000) (748,000) 9,956,000  
Beginning cash and cash equivalents         9,787,000       10,535,000 9,787,000 10,535,000 579,000  
Ending cash and cash equivalents   1,910,000       9,787,000       1,910,000 9,787,000 10,535,000  
Supplemental noncash disclosures:                          
Conversion of subordinated note to 491,830 shares of common stock                   0 0 1,003,000  
Conversion of 300 shares of Preferred Series B to 50,000 shares of common stock                   300,000 0 0  
Exchange of 31,290 shares of Preferred Series A to 5,973,519 shares of common stock                   30,604,000 0 0  
Exchange of 2,300 shares of Preferred Series B to 457,159 shares of common stock                   $ 2,260,000 $ 0 $ 0